Dr. Victor Gurewich believes he has a better way to treat strokes and heart attacks. But no one wants to hear it.
The 88-year-old Harvard Medical School professor just wants to publicize and test what could be a groundbreaking treatment, but he has struggled to be taken seriously, Stat News detailed in a report published Friday. Gurewich's treatment combines two medications to quickly break clots and reduce potential brain damage until a patient can receive angioplasty, which pushes a clot away for good.
Gurewich ran a clinical trial on the treatment 23 years ago, but the company that ran it shut down. Instead of Gurewich's method, a drug called tPA rose to prominence.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
But tPA often causes seizures and brain bleeds, making some doctors afraid to use it. Gurewich thinks he could produce a safer alternative, and with his research, he should've be able to find funding for another clinical trial by now. But some professionals shoot down Gurewich's idea, saying it's out of date. Others have never even heard it.
But when Stat explained Gurewich's proposal to one medical professional, the doctor said it was a "nifty idea," and "maybe" even a "great" one. Gurewich has some other staunch supporters who "believe in the science" behind his work.
One foundation has kept Gurewich's company afloat for years, and it's finally helping his treatment take the next step: A clinical trial of 100 patients will start in the Netherlands this June. With more funding, the treatment should get a second trial in London. Read more about Gurewich's unending determination at Stat News.
-
Is Europe finally taking the war to Russia?Today's Big Question As Moscow’s drone buzzes and cyberattacks increase, European leaders are taking a more openly aggressive stance
-
How coupling up became cringeTalking Point For some younger women, going out with a man – or worse, marrying one – is distinctly uncool
-
The rapid-fire brilliance of Tom StoppardIn the Spotlight The 88-year-old was a playwright of dazzling wit and complex ideas
-
Femicide: Italy’s newest crimeThe Explainer Landmark law to criminalise murder of a woman as an ‘act of hatred’ or ‘subjugation’ but critics say Italy is still deeply patriarchal
-
Brazil’s Bolsonaro behind bars after appeals run outSpeed Read He will serve 27 years in prison
-
Americans traveling abroad face renewed criticism in the Trump eraThe Explainer Some of Trump’s behavior has Americans being questioned
-
UN Security Council backs Trump’s Gaza peace planSpeed Read The United Nations voted 13-0 to endorse President Donald Trump’s 20-point plan to withdraw Israeli troops from Gaza
-
Chile picks leftist, far-right candidates for runoff voteSpeed Read The presidential runoff election will be between Jeannette Jara, a progressive from President Gabriel Boric’s governing coalition, and far-right former congressman José Antonio Kast
-
Venezuela mobilizes as top US warship nearsSpeed Read The largest and most advanced US aircraft carrier, the USS Gerald R. Ford, has entered the Caribbean and put Venezuela on high alert
-
Nigeria confused by Trump invasion threatSpeed Read Trump has claimed the country is persecuting Christians
-
Gaza ceasefire teeters as Netanyahu orders strikesSpeed Read Israel accused Hamas of firing on Israeli troops
